Literature DB >> 23505047

Optical/magnetic multimodal bioprobes based on lanthanide-doped inorganic nanocrystals.

Datao Tu1, Yongsheng Liu, Haomiao Zhu, Xueyuan Chen.   

Abstract

Multimodal bioprobes, which integrate the advantages of different diagnostic modes into one single particle, can overcome the current limitations of sensitivity and resolution in medical assays and significantly improve the outcome of existing therapeutics. Lanthanide-doped inorganic multimodal bioprobes, which are emerging as a promising new class of optical/magnetic multimodal bioprobes, have been long sought-after and have recently attracted revived interest owing to their distinct optical and magnetic properties. In this concept article, we introduce the controlled synthesis of lanthanide-doped inorganic multimodal bioprobes, including core-shell structured and single-phase nanoparticles, and demonstrate different design strategies for achieving dual-modal functionalization of nanoprobes. In particular, we highlight the most recent advances in biodetection, bioimaging, targeted drug delivery, and therapy based on these nanoparticles.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23505047     DOI: 10.1002/chem.201204640

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Synthesis, characterization, and cytotoxicity in human erythrocytes of multifunctional, magnetic, and luminescent nanocrystalline rare earth fluorides.

Authors:  Tomasz Grzyb; Lucyna Mrówczyńska; Agata Szczeszak; Zbigniew Śniadecki; Marcin Runowski; Bogdan Idzikowski; Stefan Lis
Journal:  J Nanopart Res       Date:  2015-10-05       Impact factor: 2.253

2.  NaGd(MoO4)2 nanocrystals with diverse morphologies: controlled synthesis, growth mechanism, photoluminescence and thermometric properties.

Authors:  Anming Li; Dekang Xu; Hao Lin; Shenghong Yang; Yuanzhi Shao; Yueli Zhang
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.